The newly FDA 510(k)-cleared Hammertoe Correction System developed by Centric Medical, Huntley, Ill, will be available beginning September 2016.
The dual-threaded-designed Hammertoe Correction System is inserted between the proximal and middle phalanges, so that the opposing threads fixate on the phalangeal canal of the toe and compress the joint.
This treatment differs from the current standard of care for hammertoe correction, in which patients are treated with wire pins (also known as “K-wires”), as well as a follow-up surgery to remove the pins.
With the Hammertoe Correction System, the implant remains with the bone, thus eliminating the need for the follow-up surgery to remove the pins, according to a media release from Centric Medical.
“Due to the advanced technology in this Hammertoe Correction System, the implant provides maintained correction through stability and compression at the PIPJ, and avoids the complications associated with K-wires,” states Dr Kyle Pearson from Rezin Orthopedics and Sports Medicine, located in Morris, Ill, in the release.
[Source(s): Centric Medical, Business Wire]